North Star Investment Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-800
| Closed | -$22K | – | 1217 |
|
|
2023
Q3 | $22K | Hold |
800
| – | – | ﹤0.01% | 717 |
|
|
2023
Q2 | $27.1K | Hold |
800
| – | – | ﹤0.01% | 700 |
|
|
2023
Q1 | $28.8K | Hold |
800
| – | – | ﹤0.01% | 709 |
|
|
2022
Q4 | $35.7K | Hold |
800
| – | – | ﹤0.01% | 653 |
|
|
2022
Q3 | $22K | Hold |
800
| – | – | ﹤0.01% | 679 |
|
|
2022
Q2 | $22K | Hold |
800
| – | – | ﹤0.01% | 692 |
|
|
2022
Q1 | $27K | Hold |
800
| – | – | ﹤0.01% | 694 |
|
|
2021
Q4 | $31K | Hold |
800
| – | – | ﹤0.01% | 705 |
|
|
2021
Q3 | $43K | Buy |
+800
| New | +$43K | ﹤0.01% | 614 |
|